Holen Sie sich die Stockscreener-App
10.75
1.42%
0.15
Handel nachbörslich:
10.75
Schlusskurs vom Vortag:
$10.60
Offen:
$10.71
24-Stunden-Volumen:
111.30K
Relative Volume:
0.37
Marktkapitalisierung:
$570.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-6.677
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
-2.54%
1M Leistung:
+4.78%
6M Leistung:
-12.24%
1J Leistung:
-49.98%
1-Tages-Spanne:
$10.61
$11.08
1-Wochen-Bereich:
$10.00
$11.08
52-Wochen-Spanne:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.75 | 563.69M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Live market analysis of Tyra Biosciences Inc.2025 Stock Rankings & Expert Curated Trade Setups - Newser
How sentiment analysis helps forecast Tyra Biosciences Inc. - Newser
What recovery options are there for Tyra Biosciences Inc.July 2025 Retail & Free Safe Entry Trade Signal Reports - Newser
Using Ichimoku Cloud for Tyra Biosciences Inc. technicals2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
Why Tyra Biosciences Inc. stock attracts strong analyst attentionRate Hike & AI Driven Stock Reports - Newser
Traders Consider Averaging Down in Tyra Biosciences Inc.2025 Biggest Moves & Real-Time Stock Movement Alerts - 선데이타임즈
Using Bollinger Bands to evaluate Tyra Biosciences Inc.2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Volume spikes in Tyra Biosciences Inc. stock – what they meanJuly 2025 Recap & Pattern Based Trade Signal System - Newser
News impact scoring models applied to Tyra Biosciences Inc.2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
Tyra Biosciences Inc. stock chart pattern explained2025 Price Action Summary & Safe Entry Trade Reports - Newser
Combining price and volume data for Tyra Biosciences Inc.2025 Stock Rankings & Expert Curated Trade Ideas - Newser
Non Muscle Invasive Bladder Cancer Pipeline Outlook Report - openPR.com
Non Muscle Invasive Bladder Cancer Pipeline Outlook Report 2025: Key 20+ Companies and Breakthrough Therapies Shaping the Future Landscape - The Globe and Mail
How to recover losses in Tyra Biosciences Inc. stockEntry Confirmation Using Short-Term Forecasting - Newser
What makes Tyra Biosciences Inc. stock attractive to long term investorsDay Trading Plan with Entry Risk Management - Newser
ETF Analysis: SCDS Expected to Reach $67 with 22.78% Upside - AInvest
Does Tyra Biosciences Inc. show high probability of reboundShort Term Profit Strategy with Entry Cues - Newser
9,047 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Purchased by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
How institutional ownership impacts Tyra Biosciences Inc. stockForecasting Stock Moves with AI Insights - Newser
Full technical analysis of Tyra Biosciences Inc. stockFree Low Capital High Return Stock Plans - Newser
What indicators show strength in Tyra Biosciences Inc.Entry Optimization Guide with Volume Analysis - Newser
Is Tyra Biosciences Inc. Forming a Consolidation BaseValue Investing Picks With Stability Outlined - beatles.ru
How to integrate Tyra Biosciences Inc. into portfolio analysis toolsFree Trend Analysis for Safer Trades - Newser
What machine learning models say about Tyra Biosciences Inc.Real-Time AI Sentiment and Price Forecast - Newser
Will Tyra Biosciences Inc. see short term momentumPattern Breakout Prediction for Short Term - Newser
Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight - Yahoo Finance
Visual trend scoring systems applied to Tyra Biosciences Inc.Buy and Hold Strategy for Capital Safety - Newser
Technical analysis overview for Tyra Biosciences Inc. stockChart Based Entry Tool for ROI Traders - Newser
Published on: 2025-08-05 13:58:12 - beatles.ru
Bank of New York Mellon Corp Sells 3,924 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Can Tyra Biosciences Inc. recover in the next quarterShort-Term Swing Opportunity Summary Sheet - Newser
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $28 - 富途牛牛
How Tyra Biosciences Inc. stock performs during market volatilityMachine Learning Stock Movement Detector - Newser
Relative strength of Tyra Biosciences Inc. in sector analysisFree Swing Trading Entry Point Signals - Newser
What are Tyra Biosciences Inc. company’s key revenue driversDiscover undervalued opportunities early - Jammu Links News
When is Tyra Biosciences Inc. stock expected to show significant growthDiscover undervalued stocks before they soar - Jammu Links News
Why is Tyra Biosciences Inc. stock attracting strong analyst attentionAchieve fast wealth growth with smart picks - Jammu Links News
What drives Tyra Biosciences Inc. stock priceRobust financial gains - Jammu Links News
What are the latest earnings results for Tyra Biosciences Inc.Overwhelming profit margins - Jammu Links News
How strong is Tyra Biosciences Inc. company’s balance sheetGet exclusive market analysis for investors - Jammu Links News
Should I hold or sell Tyra Biosciences Inc. stock in 2025Uncover the best stocks for explosive growth - Jammu Links News
Is Tyra Biosciences Inc. a growth stock or a value stockFree Wealth Planning Blueprint - Jammu Links News
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):